ACT

OCTOBER 23/2018

news roundup

Latest Business and People News

Updated employee announcements, business news, awards, and recognition in the industry today.

Advertisement

How clean is your clinical trial data?
A large group of clinical data management professionals were surveyed and 58% were not confident in the quality and completeness of their clinical data from an audit/compliance perspective.
This is a brand new, in-depth report on Challenges and Opportunities in Clinical Data Management, conducted by Pharma Intelligence and sponsored by Oracle Health Sciences.
Click here now to download the free survey report.


PAREXEL Announces New Patient-Centric Innovations to Address Drug Development Challenges

PAREXEL, a provider of global biopharmaceutical services, announced that it has developed patient-centric solutions built on its Perceptive Cloud platform to leverage mobile and wearable technology.


Advertisement

Outcomes in Focus: Best Practices for eCOA
This eBook covers considerations and practical advice for smooth eCOA implementation; secrets to eCOA success from industry insiders; and new opportunities for the use of eCOA in clinical trials.
Download Your Free eBook


Cancer Research Center Signs Multi-year Commitment to OmniComm's TrialMaster EDC

A cancer clinical research center has signed a $3.5 million commitment to OmniComm Systems, Inc., a global provider of clinical data management technology, to use its TrialMaster EDC to develop patient-centric cancer therapies.


Advertisement

Cellular Biomarkers: Predicting Clinical Trial Outcomes Through the Understanding of T-cell Responses in the Human Challenge Model
North America: Tuesday, November 13, 2018 at 11am EDT | 10am CDT | 8am PDT
Register Now


Veeva Introduces Application for Clinical Research Centers

Veeva Systems introduced its first application specifically built for clinical research centers, Veeva Vault SiteDocs. The new application is designed for sites to manage regulatory documentation and trial information and to streamline study activities.


Advertisement

Cellular Biomarkers: Predicting Clinical Trial Outcomes Through the Understanding of T-cell Responses in the Human Challenge Model
Europe: Thursday, November 8, 2018 at 3pm GMT | 4pm CET
Register Now

Advertisement

Neuropathic Pain Studies: Patient Selection, Study Design, and Clinical Trial Challenges
Tuesday, November 6, 2018 at 11am EST | 8am PST | 4pm GMT | 5pm CET
Register Now


In this edition

Latest Business and People News
Alzheimer's Clinical Trials: Obstacles and Opportunities
New Data Sharing Platform–DataCelerate–Aims to Improve Clinical Development
Comparing Risk Based Monitoring and Remote Trial Management vs. SDV

Advertisement

IDENTIFYING NASH PATIENTS: Solutions and Strategies
Thursday, November 1, 2018 at 11am EDT
Register Now


Events

eCOA / ePRO 2018
Women of Color in Pharma Second Annual Conference
2018 HBA Annual Conference
Independent Expert Committees
Pharmacovigilance Audits and Inspections Summit
Crossroads: An Artia Solutions Conference
Search Upcoming Events

Advertisement

On the brink of change: How academic data and machine learning can revolutionize Alzheimer's drug development
On Demand
Learn More


Subscribe

Subscribe

Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers »


Advertisement

Research Reveals Data Quality Issues Slow Clinical Trial Progression – What Can You Do To Prevent This?
On Demand
Learn More


Articles

Alzheimer's Clinical Trials: Obstacles and Opportunities

For sponsors who are pursuing the goal of treating Alzheimer's disease, understanding the obstacles inherent in Alzheimer's clinical trials can help in planning for, and overcoming, these challenges.


Advertisement

Artificial Intelligence: A Transformative Journey for Pharmacovigilance
On Demand
Learn More

A Roadmap to Phase I Challenges for Cell and Gene Therapy Products

Cell and gene therapies are the latest wave of advanced technologies that will shape the face of the modern-day biopharma arena, enabling a path to pinpoint a faulty gene or cellular mechanism at the root of a specific disease.


Advertisement

Challenging the Status Quo: The Diffusion of Technology in Study Startup
On Demand
Learn more


Blog Posts

Prioritizing the Patient Voice

AMPLEXOR's Dana Weiss explains the critical role of linguistic validation in enabling the patients voice.


New Data Sharing Platform–DataCelerate–Aims to Improve Clinical Development

In this interview, Michael J. Graziano, PhD, DABT, Vice-President, Drug Safety Evaluation for Bristol-Myers Squibb and leader of the BioCelerate Toxicology Data Sharing Initiative, provides more details about the DataCelerate platform.

RBM

RBM: Barriers to Adoption

The results of a 2018 survey of sponsor, CRO, and technology companies.


Comparing Risk Based Monitoring and Remote Trial Management vs. SDV

A new RBM method used in PaxVax trial proves successful vs. onsite source data verification for trial oversight.

Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription

Get the full picture


Ask the editor

Lisa Henderson
Editor in Chief
Lisa.Henderson@ubm.com

Advertise

Todd Baker
Group Publisher
todd.baker@ubm.com